Detection of medication-related problems in hospital practice: A review

British Journal of Clinical Pharmacology

Volumn 76, Issue 1, 2013, Pages 7-20

  Manias, Elizabeth ^a  

^a THE UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Clinical risk management; Error detection; Medication errors; Medication related problems; Methodology; Patient safety

Indexed keywords

ANTIARRHYTHMIC AGENT; CLOZAPINE; FIBRINOLYTIC AGENT; SPIRONOLACTONE; WARFARIN;

ADVERSE DRUG REACTION; CLINICAL PRACTICE; COMPUTER MONITORING; DATA COLLECTION METHOD; DIAGNOSTIC ACCURACY; DIRECT CARE OBSERVATION; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG INDUCED DISEASE; ELECTRONIC MEDICAL RECORD; HOSPITALIZATION; HUMAN; HYPOKALEMIA; INCIDENT REPORT; INTERVIEW; MEDICAL RECORD REVIEW; MEDICATION ERROR; OBSERVATION; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE DATA COLLECTION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREND STUDY;

DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HOSPITALS; HUMANS; MEDICATION ERRORS; SENSITIVITY AND SPECIFICITY;

EID: 84879479519     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12049     Document Type: Review

References (56)

1. Bates DW. Preventing medication errors: a summary. Am J Health Syst Pharm 2007; 64: S3-S9.
2. Meyer-Massetti C, Cheng CM, Schwappach DLB, Paulsen L, Ide B, Meier CR, Guglielmo BJ. Systematic review of medication safety assessment methods. Am J Health Syst Pharm 2011; 68: 227-240.
3. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199-205.
4. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801.
5. Azaz-Livshits T, Levy M, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 1998; 45: 309-314.
6. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8: 289-294.
7. Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm 1988; 45: 1534-1539.
8. Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009; 9: 8. doi: 10.1186/472-6904-9-8.
9. Dalton-Bunnow M, Halvachs FJ. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial. Hosp Pharm 1993; 28: 752-755.
10. Dormann H, Criegee-Rieck M, Neubert A, Egger T, Levy M, Hahn EG, Brune K. Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther 2004; 19: 303-309.
11. Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M, Gassmann KG, Brune K. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003; 20: 769-776.
12. Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc 2004; 11: 492-498.
13. Flynn EA, Barker KN, Pepper GA, Bates DW, Mikeal RL. Comparison of methods for detecting medication errors in 36 hospitals and skilled-nursing facilities. Am J Health Syst Pharm 2002; 59: 436-446.
14. Franklin BD, O'Grady K, Paschalides C, Utley M, Gallivan S, Jacklin A, Barber N. Providing feedback to hospital doctors about prescribing errors; a pilot study. Pharm World Sci 2007; 29: 213-220.
15. Franklin BD, Birch S, Savage I, Wong I, Woloshynowych M, Jacklin A, Barber N. Methodological variability in detecting prescribing errors and consequences for the evaluation of interventions. Pharmacoepidemiol Drug Saf 2009; 18: 992-999.
16. Franklin BD, Birch S, Schachter M, Barber N. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract 2010; 18: 305-311.
17. Grasso BC, Genest R, Jordan CW, Bates DW. Use of chart and record reviews to detect medication errors in a state psychiatric hospital. Psychiatr Serv 2003; 54: 677-681.
18. Haw C, Stubbs J, Dickens G. An observational study of medication administration errors in old-age psychiatric inpatients. Int J Qual Health Care 2007; 19: 210-216.
19. Hogan H, Olsen S, Scobie S, Chapman E, Sachs R, McKee M, Vincent C, Thomson R. What can we learn about patient safety from information sources within an acute hospital: a step on the ladder of integrated risk management? Qual Saf Health Care 2008; 17: 209-215.
20. Honigman B, Lee J, Rothschild J, Light P, Pulling RM, Yu T, Bates DW. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8: 254-266.
21. Hope C, Overhage M, Seger A, Teal E, Mills V, Fiskio J, Gandhi TK, Bates DW, Murray MD. A tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug events. J Biomed Inform 2003; 36: 92-98.
22. Huang C, Noirot L, Reichley R, Bouselli D, Dunagan C, Bailey T. Automatic detection of spironolactone - related adverse drug events. AMIA Ann Sympos Proceedings 2005; 989.
23. Hwang SH, Lee S, Koo HK, Kim Y. Evaluation of a computer-based adverse-drug-event monitor. Am J Health Syst Pharm 2008; 65: 2265-2272.
24. Jha AK, Kuperman GJ, Teich JM, Leape L, Shea B, Rittenberg E, Burdick E, Seger DL, Vander Vliet M, Bates DW. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5: 305-314.
25. Kozer E, Scolnik D, Jarvis AD, Koren G. The effect of detection approaches on the reported incidence of tenfold errors. Drug Safety 2006; 29: 169-174.
26. Kunac DL, Reith DM. Preventable medication-related events in hospitalised children in New Zealand. N Z Med J 2008; 121: 17-32.
27. Levy M, Azaz-Livshits T, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54: 887-892.
28. Nebeker J, Yarnold P, Soltysik R, Sauer B, Sims S, Samore M, Rupper R, Swanson K, Savitz L, Shinogle J, Xu W. Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data. Med Care 2007; 45: S81-88.
29. Neubert A, Dormann H, Weiss J, Criegee-Rieck M, Ackermann A, Levy M, Brune K, Rascher W. Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 2006; 62: 959-965.
30. Olsen S, Neale G, Schwab K, Psaila B, Patel T, Chapman EJ, Vincent C. Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place. Quality & Safety Health Care 2007; 16: 40-44.
31. O'Neil AC, Petersen LA, Cook F, Bates DW, Lee TH, Brennan TA. Physician reporting compared with medical record review to identify adverse medical events. Ann Intern Med 1993; 119: 370-376.
32. Sari AB-A, Sheldon TA, Cracknell A, Turnbull A. Group sensitivity of routine system for reporting patient safety incidents in an NHS hospital: retrospective patient case note review. Br Med J 2007; 334: 79-81.
33. Savage I, Cornford T, Klecun E, Barber N, Clifford S, Franklin BD. Medication errors with electronic prescribing (eP): two views of the same picture. BMC Health Serv Res 2010; 10: 135. doi: 10.1186/472-6963-10-135.
34. Seger AC, Jha AK, Bates DW. Adverse drug event detection in a community hospital utilising computerised medication and laboratory data. Drug Safety 2007; 30: 817-824.
35. Stanhope N, Crowley-Murphy M, Vincent C, O'Connor AM, Taylor-Adams SE. An evaluation of adverse incident reporting. J Eval Clin Pract 1999; 5: 5-12.
36. Weissman JS, Schneider EC, Weingart SN, Epstein AM, David-Kasdan JA, Feibelmann S, Annas CL, Ridley N, Kirle L, Gatsonis C. Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not? Ann Intern Med 2008; 149: 100-108.
37. Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Schneider HT, Hahn EG, Levy M, Brune K, Geisslinger G. Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Safety 2000; 22: 161-168.
38. Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment. Pediatrics 2008; 121: e1201-1207.
39. Haffner S, Von Laue N, Wirth S, Thürmann PA. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Safety 2005; 28: 453-464.
40. Whipple JK, Quebberman EJ, Lewis KS, Gaughan LM, Gallup EL, Ausman RK. Identification of patient-controlled analgesia overdoses in hospitalized patients: a computerized method of monitoring adverse events. Ann Pharmacother 1994; 28: 655-658.
41. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. Quality & Safety Health Care 2005; 14: 221-226.
42. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006; 13: 372-377.
43. Schade CP, Hannah K, Ruddick P, Starling C, Brehm J. Improving self reporting of adverse drug events in a West Virginia Hospital. Am J Med Qual 2006; 21: 335-341.
44. Takata GS, Taketomo CK, Waite S, for the California Pediatric Patient Safety Initiative. Characteristics of medication errors and adverse drug events in hospitals participating in the California Pediatric Patient Safety Initiative. Am J Health Syst Pharm 2008; 65: 2036-2044.
45. Capuzzo M, Nawfal I, Campi M, Valpondi V, Verri M, Alvisi R. Reporting of unintended events in an intensive care unit: comparison between staff and observer. BMC Emerg Med 2005; 5: 3. doi: 10.1186/471-227X-5-3.
46. Viktil KK, Blix HS, Moger TA, Reikvam A. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 2006; 15: 667-674.
47. Bennett BS, Lipman AG. Comparative study of prospective surveillance and voluntary reporting in determining the incidence of adverse drug reactions. Am J Hosp Pharm 1977; 34: 931-936.
48. Thuermann PA, Windecker R, Steffen J, Schaefer M, Tenter U, Reese E, Menger H, Schmitt K. Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Safety 2002; 25: 713-724.
49. Forster AJ, Jennings A, Chow C, Leeder C, van Walraven C. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc 2012; 19: 31-38.
50. Hicks RW, Becker SC, Cousins DD. Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX(R) program. J Pediatr Nurs 2006; 21: 290-298.
51. Semple SJ, Roughead ER. Medication safety in acute care in Australia: where are we now? Part 2: a review of strategies and activities for improving medication safety 2002-2008. Aust NZ Health Pol 2009; 6: 24. doi: 10.1186/743-8462-6-24.
52. Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience. Arch Dis Child 2000; 83: 492-496.
53. Montesi G, Lechi A. Prevention of medication errors: detection and audit. Br J Clin Pharmacol 2009; 67: 651-655.
54. Manias E, Gerdtz MF, Weiland TJ, Collins M. Medication use across transition points from the emergency department: identifying factors associated with medication discrepancies. Ann Pharmacother 2009; 43: 1755-1764.
55. Stockwell DC, Kane-Gill SL. Developing a patient safety surveillance system to identify adverse events in the intensive care unit. Crit Care Med 2010; 38: S117-125.
56. Hogan H, Olsen S, Scobie S, Chapman E, Sachs R, McKee M, Vincent C, Thomson R. What can we learn about patient safety from information sources within an acute hospital: a step on the ladder of integrated risk management? Qual Saf Health Care 2008; 17: 209-215.